Notably, compounds like Trifluoperazine and ZZW‐115, traditionally used for psychiatric symptoms, have been identified as selective inhibitors of NUPR1, highlighting its potential as a cancer therapy target.[19] Nevertheless, the research has predominantly focused on NUPR1 within tumor cells, with its role in the TME remaining underexplored. Here, NUPR1 is linked to cancer.